Topic Highlight
Copyright ©2013 Baishideng Publishing Group Co.
World J Cardiol. Dec 26, 2013; 5(12): 453-458
Published online Dec 26, 2013. doi: 10.4330/wjc.v5.i12.453
Table 1 Beta-blocking agents
B-blockersSelectivityPartial agonist activityLipid solubilityOnsetHemodynamic effectPlasma half-lifeElimination’s route
Generic nameOralIVOralIV
Acebutolol hydrochlorideβ1YesLow1-2 hNo> 24 hNo3-4 hHepatic, renal
Atenololβ1NoLow1 h1-2 min  24 h12 h6-9 hRenal
Betaxolol hydrochlorideβ1NoLow24 hNo> 24 hNo12-22 hHepatic, renal
Bisoprololβ1NoLow1-4 hNo 24 hNo7-15 hHepatic, renal
Esmololβ1NoLowNo1-4 minNo5-10 min4-9 minErythrocyte, renal
Metoprolol tartrateβ1NoModerate1 h5-10 min5-8 h3-7 hHepatic
Metoprolol succinateβ1NoModerate2-3 hNo 24 hNo3-7 hHepatic
NadololNoneNoLow1-2 hNo 24 hNo20-24 hRenal
PindololNoneYesModerate1-2 hNo 24 hNo3-4 hHepatic, renal
Propranolol hydrochlorideNoneNoHigh30 min< 1 min6-12 h4-6 h3.5-6 hHepatic